StockNews.com started coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a research note published on Wednesday. The firm issued a hold rating on the biotechnology company’s stock.
Bellerophon Therapeutics Price Performance
Shares of Bellerophon Therapeutics stock opened at $0.04 on Wednesday. The company has a market cap of $428,155.00, a PE ratio of -0.04 and a beta of 0.73. The firm has a fifty day moving average price of $0.05 and a two-hundred day moving average price of $0.05. Bellerophon Therapeutics has a fifty-two week low of $0.03 and a fifty-two week high of $0.52.
About Bellerophon Therapeutics
Featured Articles
- Five stocks we like better than Bellerophon Therapeutics
- Upcoming IPO Stock Lockup Period, Explained
- The Solar Stock Battle: Is Daqo or JinkoSolar Your Next Big Win?
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Are These Chinese Stocks a Buy? Michael Burry’s Top Picks Say Yes
- What is Short Interest? How to Use It
- Five Below Stock Faces Challenges Despite Strong Revenue Growth
Receive News & Ratings for Bellerophon Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bellerophon Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.